| Item | Content |
|---|
| Research project name |
Practical Research Project for Rare / Intractable Diseases |
| Study title |
An investigator-initiated clinical trial of rituximab in patients with steroid resistant pemphigus |
| Name of principal investigator |
Masayuki Amagai |
| Name of institution of the principal investigator |
Department of Dermatology, Keio University School of Medicine |
| Target disease |
Pemphigus |
| Registry name |
Registry study on patients with pemphigus |
| Purpose of registry |
Patient recruitment for clinical trials or other interventional studies
|
| Overview of registry |
An investigator-initiated clinical trial to investigate efficacy and safety of rituximab for steroid resistant pemphigus is being conducted. The objective of this registry is rapid case series by understanding of the candidate subjects of the planned investigator-initiated clinical trial (study title: An investigator-initiated open-label, single-arm, multicenter phase II clinical study on IDEC-C2B8 in patients with steroid resistant pemphigus. Hereinafter, “P-IDEC study”) by the study group with the registry. It is considered significant if the study group understands the candidate subjects with this registry because rapid consideration whether rituximab is effective for steroid resistant pemphigus becomes possible.
|
| Research item |
Sex, Date of birth, Others (Age, year of diagnosis of pemphigus, disease type (vulgaris, foliaceus, paraneoplastic, others), present dose of steroid)
|
| Contact |
Jun Yamagami |
| E-mail address |
yamagamijun●keio.jp |
| Registry URL |
|
* If the E-mail address is shown, replace "●" with "@", please.
